1. Bedard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J. 2009; 30:256–65.
2. Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol. 1998; 31:1650–7.
Article
3. European Society of Gynecology (ESG) , Association for European Paediatric Cardiology (AEPC) , German Society for Gender Medicine (DGesGM) , Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011. 32:p. 3147–97.
4. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009; 119:2250–94.
5. Hwang IH, Choi JW, Hwang EK, Mun CH, Min HC, Song CS. A case of primary pulmonary hypertension associated with pregnancy. Korean Circ J. 1997; 27:881–6.
Article
6. Min HS, Chang HJ, Cho YS, Youn TJ, Chung WY, Chae IH, et al. Portopulmonary hypertension in pregnancy: Treatment with sildenafil. Korean J Med. 2007; 73:200–5.
7. Bonnin M, Mercier FJ, Sitbon O, Roger-Christoph S, Jais X, Humbert M, et al. Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology. 2005; 102:1133–7.
8. Hill CC, Pickinpaugh J. Physiologic changes in pregnancy. Surg Clin North Am. 2008; 88:391–401. vii.
Article
9. Huang S, DeSantis ER. Treatment of pulmonary arterial hypertension in pregnancy. Am J Health Syst Pharm. 2007; 64:1922–6.
Article
10. Stewart R, Tuazon D, Olson G, Duarte AG. Pregnancy and primary pulmonary hypertension: successful outcome with epoprostenol therapy. Chest. 2001; 119:973–5.
11. Bendayan D, Hod M, Oron G, Sagie A, Eidelman L, Shitrit D, et al. Pregnancy outcome in patients with pulmonary arterial hypertension receiving prostacyclin therapy. Obstet Gynecol. 2005; 106(5 Pt 2):1206–10.
Article
12. Elkayam U, Dave R, Bokhari SW. Primary pulmonary hyper-tension and pregnancy. Elkayam U, Gleicher N, editors. Cardiac problems in pregnancy: diagnosis and management of maternal and fetal disease. 3rd ed. New York: Wiley-Liss Inc.;1998. p. 83–90.
13. Schachna L, Wigley FM, Chang B, White B, Wise RA, Gelber AC. Age and risk of pulmonary arterial hypertension in scleroderma. Chest. 2003; 124:2098–104.
Article
14. Lange AP. Prostaglandins as abortifacients in Denmark. Acta Obstet Gynecol Scand Suppl. 1983; 113:117–24.
Article
15. Barash PG, Nardi D, Hammond G, Walker-Smith G, Capuano D, Laks H, et al. Catheter-induced pulmonary artery perforation. Mechanisms, management, and modifications. J Thorac Cardiovasc Surg. 1981; 82:5–12.
16. Kim SJ, Cha JH, Lee HR, Hong YM. Effects of bosentan treatment on angiotensin converting enzyme in monocrotaline induced pulmonary hypertension rats. J Korean Soc Hypertens. 2011; 17:28–36.
Article
17. Kim WS, Park SH, Choi HJ, Han JJ. A case of sustained severe pulmonary hypertension after sugrical repair of atrial septal defect in a patient with HIV infection. J Korean Soc Hypertens. 2010; 16:35–40.
18. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med. 2004; 351:1425–36.
Article
19. Bildirici I, Shumway JB. Intravenous and inhaled epoprostenol for primary pulmonary hypertension during pregnancy and delivery. Obstet Gynecol. 2004; 103(5 Pt 2):1102–5.
Article
20. Avdalovic M, Sandrock C, Hoso A, Allen R, Albertson TE. Epoprostenol in pregnant patients with secondary pulmonary hypertension: two case reports and a review of the literature. Treat Respir Med. 2004; 3:29–34.
21. Madden BP, Sheth A, Wilde M, Ong YE. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease? Vascul Pharmacol. 2007; 47:184–8.
22. Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC) , European Respiratory Society (ERS) , International Society of Heart and Lung Transplantation (ISHLT) , Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2009; 34:1219–63.
23. Higton AM, Whale C, Musk M, Gabbay E. Pulmonary hypertension in pregnancy: two cases and review of the literature. Intern Med J. 2009; 39:766–70.
Article
24. Terek D, Kayikcioglu M, Kultursay H, Ergenoglu M, Yalaz M, Musayev O, et al. Pulmonary arterial hypertension and pregnancy. J Res Med Sci. 2013; 18:73–6.
25. Warnes CA. Pregnancy and pulmonary hypertension. Int J Cardiol. 2004; 97(Suppl 1):11–3.
Article